Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer
Yulai Zhou, Xiangyang Zhang, Yan Gao, Yinghui Peng, Ping Liu, Yihong Chen, Cao Guo, Gongping Deng, Yanhong Ouyang, Yan Zhang, Ying Han, Changjing Cai, Hong Shen, Le Gao, Shan Zeng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNeuropeptides and Animal Physiology · Cancer, Stress, Anesthesia, and Immune Response · Chemokine receptors and signaling
Main text
(iScience 27, 110318; July 19, 2024)
Post-publication, a reader contacted the journal to raise concerns on data and findings presented in this manuscript. In response, the journal promptly initiated an investigation and contacted the corresponding authors for clarification. The authors acknowledged honest mistakes in the assembly of Figure 7D and provided a satisfactory explanation along with raw data. The revised version of Figure 7 is included below. The authors would like to thank the reader and apologize for any confusion or inconvenience this issue may have caused.Figure 7. The function of NMUR1 in CRC cell lines